Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Mike Zach
- Mingyan Li
- Sam Hollifield
- Andrew F May
- Ben Garrison
- Brad Johnson
- Brian Weber
- Bruce Moyer
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Hsin Wang
- Huixin (anna) Jiang
- Isaac Sikkema
- James Klett
- Jamieson Brechtl
- Jeffrey Einkauf
- Jennifer M Pyles
- John Lindahl
- Joseph Olatt
- Justin Griswold
- Kai Li
- Kashif Nawaz
- Kevin Spakes
- Kunal Mondal
- Kuntal De
- Laetitia H Delmau
- Lilian V Swann
- Luke Koch
- Luke Sadergaski
- Mahim Mathur
- Mary A Adkisson
- Nedim Cinbiz
- Oscar Martinez
- Padhraic L Mulligan
- Sandra Davern
- T Oesch
- Tony Beard
- Xiaobing Liu

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

Moisture management accounts for over 40% of the energy used by buildings. As such development of energy efficient and resilient dehumidification technologies are critical to decarbonize the building energy sector.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

Real-time tracking and monitoring of radioactive/nuclear materials during transportation is a critical need to ensure safety and security. Current technologies rely on simple tagging, using sensors attached to transport containers, but they have limitations.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.